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1. Introduction
About 20 years ago, actor Michael J. Fox—well known for the trilogy “Back to 
the Future” and at the time at the height of his success and of his youth—declared 
to the public that he had received the unexpected diagnosis of Parkinson’s disease 
(PD) 7 years before. On the same occasion, Michael announced the decision to put 
his image at the service of what would become one of the most lasting and decisive 
campaigns of hope, information, awareness, and fundraising for research in the 
fight against PD. About 20 years later, what progress has actually been made?
As is known, Parkinson’s disease does not yet have a cure. The fundamental 
therapy is still the pharmacological one, which is implemented today with the 
administration of various active ingredients in addition to levodopa which remains 
the most powerful drug, but which presents marked side effects after a few years. 
2018 was a special year for people with Parkinson’s and their loved ones. It started 
in January with the shocking news of the decision by the pharmaceutical company 
Pfizer to suspend all research related to treatments for Parkinson’s and Alzheimer’s 
because they were too expensive, to continue with the announcement by researchers 
at Johns Hopkins University to have obtained results, still preliminary but extremely 
encouraging, with the drug called NLY01. With regard to non-pharmacological 
interventions, we note the progress of neuronal stem cell experimentation carried 
out in Australia by the International Stem Cell Corporation (ISCO), which, accord-
ing to what the company reported, looks very promising. These are the first steps 
and the path will still be long, but these are just some of the researches that keep 
hope for the future alive.
Innovative ideas and therapies for PD go far beyond a single drug or stem cell. 
There is a broader and more exciting picture. Innovative ideas include drugs, cells, 
vaccine, ICT-IoT devices, genetics, social care, and cognitive-behavioral enhance-
ment. The most recent therapeutic approaches have highlighted the importance of 
the multidisciplinary perspective and the usefulness of rehabilitation, both in its 
“classic” form as physiotherapy and in one or more of the so-called “complementary 
therapies” (indicating that they complement but do not replace approaches that 
are more conventional). Patients and their families should be kept informed and 
updated on all potential innovative therapies. Above all, their needs should be at 
the center of the healthcare process and the research initiatives. Some of the most 
frequent questions we receive from parkinsonian patients and families are “How can 
I be cured?,” “What will be the next breakthrough?,” and “For everything else what 
do I do now?”
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Because of the complexity of the disease, each patient has a different combina-
tion of motor and non-motor symptoms, of difficulties in daily life. This complexity 
therefore means that the answer to the next possible innovative therapy will vary 
from patient to patient—and could be an innovation in care, as well as, possibly, a 
new ICT-IoT device or a new cocktail of drugs. We will need to expand our notion 
of innovation, and we will need to exploit this knowledge to reduce the burden of 
Parkinson’s patients. This introductory chapter therefore aims to answer the funda-
mental question: What are the unmet needs in Parkinson’s disease?
2.  Unmet needs in Parkinson’s disease: new horizons in the clinic and in 
research
PD patients fight against a range of physical motor symptoms including slow-
ness of movement, rigidity, tremor, and postural instability. However, this is the 
not the full story. They also experience many other non-motor symptoms, which 
affect their daily living, sometimes in ways that are just as important to them as the 
cardinal motor symptoms of the disease.
The awareness has now been reached that non-motor symptoms burden is a key 
determinant of quality of life of patients and their primary caregivers [1, 2].
Treating these kinds of symptoms that negatively influence the lives of 
patients—and in particular those that are responsive to the dopaminergic replace-
ment therapy—automatically translates into improvements in quality of life and 
reduction of the associated burden [3].
However, clinicians often regard non-motor symptoms and their management as 
peripheral to that of the motor symptoms. Just for an example, the 2011 Parkinson’s 
UK report showed non-motor symptoms recorded in only 21% of elderly care and 
9% of neurology services in the UK.
Nevertheless, Hatano and collaborators [4] suggested that PD patients have 
unmet needs in their treatment and standards of care already in 2009. In particular, 
the authors suggested focusing on the development of better treatment for motor 
symptoms, the development of new treatments for non-motor symptoms and 
improved two-way communication between patient and physician.
Chaudhuri et al. reported a few years later: “Key medical unmet needs in PD 
include the need for better animal models replicating the parkinsonian process, slow-
ing of disease progression/neuroprotection, improved biomarkers (imaging, genetic, 
clinical or other modality), improved 24-h control of motor fluctuations in moderate 
to advanced disease and more effective treatment of non-motor symptoms (NMS). 
Nocturnal symptoms as well as early morning fluctuations remain also neglected” 
([5], p. 52). To confirm the above, in their study on Palliative Needs of Parkinson’s 
Patients, Prizer and colleagues [6] have shown that among the palliative needs most 
frequently reported by patients, there were: healthcare education, care coordination, 
support groups, spirituality/religion, and the greater presence of the neurologist.
How to address the unmet needs of people living with Parkinson’s disease? We 
need a person-centered perspective.
It is proposed this year an interesting approach called the “Voice of the 
Costumer” [7], which includes three successive phases of gathering information 
on the real needs due to the experience of the disease: (1) capturing patient needs 
by means of semi-structured interviews with patients, relatives, and healthcare 
providers in their private environment; (2) preparing a comprehensive summary of 
the contents discussed in the interviews; and (3) prioritizing needs in a consensus 
meeting, in which all parties participate. Vlaanderen and collaborators [7] sug-
gested that patients were more concerned about the impact of PD on their daily 
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lives than about the bio-medical aspects of the disease. The authors have found 
that top unmet needs of the parties involved were: more self-management; better 
interdisciplinary collaboration between different healthcare professionals; more 
time to discuss the future and possible scenarios; and a healthcare professional 
acting as a single point of access, acting as personal case manager, either to solve 
problems directly or to direct patients to the professional best equipped to address 
the problem at hand.
Another useful tool could be the Parkinson’s Well-Being Map™—developed in 
partnership with the European Parkinson’s Disease Association (EPDA), the Cure 
Parkinson’s Trust, and the Spanish Federation of Parkinson’s Disease—which takes a 
holistic approach, allowing patients to track both motor and underlying symptoms. 
The map helps PD patients to prepare for consultations with their healthcare team, 
so that they can help to understand how living with Parkinson’s disease affects 
them. The map covers all aspects of Parkinson’s, so that a patient can highlight the 
symptoms that are of most concern to him/her and list the most important ques-
tions to ask at his/her next consultation. It was made available free online and in 
paper form.
Approaches of this kind can help clinicians and researchers to better plan their 
activities so that in the future, gaps in the current methods of management are 
filled and research topics are expanded based on a patient-centered approach.
3. The nature and purpose of the book
The volume aims to bring together in a single publication the knowledge on the 
topic of diagnosis, characterization of the clinical and neuropsychological profile in 
Parkinson’s disease. The strong impulse given to research on this topic has produced 
in recent years a large literature that documents the high level of complexity of the 
issue, for which a reasoned multidimensional analysis able to integrate expertise 
of different disciplines (neurology, neuropsychology, neuroradiology, and clinical 
neuroscience) is necessary.
The volume illustrates the neuropathological characteristics that define 
Parkinson’s disease. Subsequent contributions focus on the diagnostic characteriza-
tion and monitoring of Parkinson’s disease, considering also the contribution of 
neuropsychology, morphological and functional imaging techniques.
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